{"title":"Short Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up","link":"https://www.preprints.org/manuscript/202408.0746/v1","date":1723458999000,"content":"Short-cycle therapy has proven to be a safe and effective alternative to standard everyday antiretroviral treatment for virally suppressed people living with HIV. Here we report a favorable long-term virological and immunological outcome in 12 virally suppressed people on short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide administered five days a week (Monday to Friday).","author":"","siteTitle":"Preprints.org - The Multidisciplinary Preprint Platform","siteHash":"abac34b0506002eba4392ac15186820b9b5d7a0f2e5fce3a3511408258fb1a7e","entryHash":"456086e24fde4fb4d89471f7cfe95c33d0c90a64fa7cb56af2ad9a284a164a78","category":"Interdisciplinary"}